News
Moderna, FDA and Covid
Digest more
1h
WOODTV.com on MSNModerna gets full FDA approval for kids COVID-19 vaccineThe company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
Moderna stock jumps 4.5% as the FDA grants full approval for its COVID-19 vaccine in high-risk individuals aged six months to ...
Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform ...
Major health groups sue HHS and Robert F. Kennedy Jr. over COVID-19 vaccine policy changes for children and pregnant ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results